The closing price of Chico’s FAS Inc. (NYSE: CHS) was 4.95 for the day, down -3.13% from the previous closing price of $5.11. In other words, the price has decreased by $-0.1600 from its previous closing price. On the day, 1884229 shares were traded. CHS reached its highest trading level at $5.0200 during the session, while it also had its lowest trading level at $4.8500.
Our analysis of CHS’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.63 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 7.26. For the most recent quarter (mrq), Quick Ratio is recorded 0.50 and its Current Ratio is at 1.20. In the meantime, Its Debt-to-Equity ratio is 0.33 whereas as Long-Term Debt/Eq ratio is at 0.33.
Upgrades & Downgrades
On November 27, 2019, Telsey Advisory Group reiterated its Market Perform rating and also lowered its target price recommendation from $3 to $5.
Telsey Advisory Group reiterated its Market Perform rating for the stock on August 29, 2019, while the target price for the stock was revised from $4 to $3.
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jun 21 when Brooks Bonnie R. sold 100,000 shares for $5.57 per share. The transaction valued at 557,000 led to the insider holds 1,185,277 shares of the business.
Brooks Bonnie R. sold 100,000 shares of CHS for $512,000 on Jun 08. The Executive Chair of the Board now owns 1,285,277 shares after completing the transaction at $5.12 per share. On Mar 16, another insider, Brooks Bonnie R., who serves as the Executive Chair of the Board of the company, sold 200,000 shares for $4.28 each. As a result, the insider received 856,000 and left with 1,421,186 shares of the company.
As of this moment, Chico’s’s Price-to-Earnings (P/E) ratio for their current fiscal year is 5.81, and their Forward P/E ratio for the next fiscal year is 5.21. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.58. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.31 while its Price-to-Book (P/B) ratio in mrq is 2.00.
Stock Price History:
Over the past 52 weeks, CHS has reached a high of $7.19, while it has fallen to a 52-week low of $3.80. The 50-Day Moving Average of the stock is 5.7400, while the 200-Day Moving Average is calculated to be 5.1157.
CHS traded an average of 2.33M shares per day over the past three months and 2.48M shares per day over the past ten days. A total of 125.09M shares are outstanding, with a floating share count of 120.76M. Insiders hold about 2.90% of the company’s shares, while institutions hold 85.50% stake in the company. Shares short for CHS as of Jul 14, 2022 were 10.1M with a Short Ratio of 4.70, compared to 11.16M on Jun 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 8.07% and a Short% of Float of 9.99%.
Dividends & Splits
The current Payout Ratio is 0.00% for CHS, which recently paid a dividend on Mar 29, 2020 with an ex-dividend date of Mar 12, 2020. Stock splits for the company last occurred on Feb 22, 2005 when the company split stock in a 2:1 ratio.
The firm’s stock currently is rated by 2 analysts. On average, analysts expect EPS of $0.25 for the current quarter, with a high estimate of $0.26 and a low estimate of $0.24, while EPS last year was $0.21. The consensus estimate for the next quarter is $0.11, with high estimates of $0.11 and low estimates of $0.11.
Analysts are recommending an EPS of between $0.72 and $0.71 for the fiscal current year, implying an average EPS of $0.71. EPS for the following year is $0.79, with 2 analysts recommending between $0.81 and $0.77.
A total of 2 analysts have provided revenue estimates for CHS’s current fiscal year. The highest revenue estimate was $2.15B, while the lowest revenue estimate was $2.14B, resulting in an average revenue estimate of $2.15B. In the same quarter a year ago, actual revenue was $1.81B, up 18.70% from the average estimate. Based on 2 analysts’ estimates, the company’s revenue will be $2.26B in the next fiscal year. The high estimate is $2.27B and the low estimate is $2.26B. The average revenue growth estimate for next year is up 5.30% from the average revenue estimate for this year.